Insulin aspart, recombinant Subcutaneous and Medihaler Ergotamine
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Medihaler Ergotamine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: ergotamine
Brand name: Ergomar
Synonyms: Ergotamine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Medihaler-Epi
- Insulin aspart, recombinant Subcutaneous-Medihaler-Iso
- Insulin aspart, recombinant Subcutaneous-Mediplast
- Insulin aspart, recombinant Subcutaneous-Mediplast Topical
- Insulin aspart, recombinant Subcutaneous-Medolor Pak
- Insulin aspart, recombinant Subcutaneous-Medotar
- Medihaler Ergotamine-Insulin degludec
- Medihaler Ergotamine-Insulin Degludec (U-100) Prefilled Pens
- Medihaler Ergotamine-Insulin Degludec (U-100) Vials
- Medihaler Ergotamine-Insulin Degludec (U-200) Prefilled Pens
- Medihaler Ergotamine-Insulin degludec and liraglutide
- Medihaler Ergotamine-Insulin degludec and liraglutide Subcutaneous